Trends in adjuvant therapies after breast-conserving surgery for hormone receptor-positive ductal carcinoma in situ: findings from the National Cancer Database, 2004

Trends in adjuvant therapies after breast-conserving surgery for hormone receptor-positive ductal carcinoma in situ: findings from the National Cancer Database, 2004–2013

Published:2017-08-03 Issue:2 Volume:166 Page:583-592
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Sagara Yasuaki^ORCID,Freedman Rachel A.,Wong Stephanie M.,Aydogan Fatih,Nguyen Anvy,Barry William T.,Golshan Mehra

Funder

Breast Cancer Research Foundation

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/article/10.1007/s10549-017-4436-9/fulltext.html

Reference30 articles.

1. Welch HG, Prorok PC, O’Malley AJ et al (2016) Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness. N Engl J Med 375(15):1438–1447. doi: 10.1056/NEJMoa1600249

2. Siegel R, Miller K, Jemal A (2015) Cancer statistics, 2015. CA Cancer J Clin 65(1):29. doi: 10.3322/caac.21254

3. Virnig BA, Shamliyan T, Tuttle TM et al (2009) Diagnosis and management of ductal carcinoma in situ (DCIS). Evid Rep Technol Assess (Full Rep). 185:1–549

4. Narod SA, Iqbal J, Giannakeas V et al (2015) Breast cancer mortality after a diagnosis of ductal carcinoma in situ. JAMA Oncol 1(7):888–896. doi: 10.1001/jamaoncol.2015.2510

5. Sagara Y, Freedman RA, Vaz-Luis I et al (2016) Patient prognostic score and associations with survival improvement offered by radiotherapy after breast-conserving surgery for ductal carcinoma in situ: a population-based longitudinal cohort study. J Clin Oncol 34(11):1190–1196. doi: 10.1200/JCO.2015.65.1869

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Expression Assays Improve the Prediction of Local and Invasive Local Recurrence After Breast-Conserving Surgery for Ductal Carcinoma In Situ;Journal of Clinical Oncology;2024-06-28

2. Can Molecular Biomarkers Help Reduce the Overtreatment of DCIS?;Current Oncology;2023-06-13

3. Individualized estimates of intensity-modulated radiotherapy plans after breast conservation surgery for left-sided breast cancer;World Journal of Surgical Oncology;2023-02-23

4. Factors associated with ductal carcinoma in situ (DCIS) treatment patterns and patient-reported outcomes across a large integrated health network;Breast Cancer Research and Treatment;2022-12-17

5. DCIS: Risk Assessment in the Molecular Era;Seminars in Radiation Oncology;2022-07